Royal Bank of Canada
BCYC

Royal Bank of Canada’s Bicycle Therapeutics BCYC Stock Holding History

Royal Bank of Canada’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67K Buy
14,470
+3,788
+35% +$21.6K ﹤0.01% 5343
2025
Q4 		$76K Sell
10,682
-2,051
-16% -$15.1K ﹤0.01% 5336
2025
Q3 		$99K Buy
12,733
+2,371
+23% +$17.9K ﹤0.01% 5514
2025
Q2 		$72K Sell
10,362
-7,578
-42% -$60.4K ﹤0.01% 5759
2025
Q1 		$152K Buy
17,940
+8,167
+84% +$96.2K ﹤0.01% 4905
2024
Q4 		$137K Buy
9,773
+9,310
+2,011% +$200K ﹤0.01% 5123
2024
Q3 		$11K Hold
463
– – ﹤0.01% 6298
2024
Q2 		$9K Buy
463
+176
+61% +$3.98K ﹤0.01% 6362
2024
Q1 		$7K Sell
287
-59
-17% -$1.25K ﹤0.01% 6314
2023
Q4 		$6K Sell
346
-189
-35% -$3.13K ﹤0.01% 6607
2023
Q3 		$11K Buy
535
+153
+40% +$3.5K ﹤0.01% 6376
2023
Q2 		$10K Buy
382
+189
+98% +$4.39K ﹤0.01% 6465
2023
Q1 		$4K Sell
193
-18
-9% -$451 ﹤0.01% 6609
2022
Q4 		$7K Buy
211
+3
+1% +$80 ﹤0.01% 6644
2022
Q3 		$4K Buy
208
+18
+9% +$428 ﹤0.01% 6793
2022
Q2 		$3K Sell
190
-57
-23% -$1.2K ﹤0.01% 6804
2022
Q1 		$11K Buy
247
+96
+64% +$4.48K ﹤0.01% 6896
2021
Q4 		$9K Buy
151
+47
+45% +$2.59K ﹤0.01% 7074
2021
Q3 		$4K Buy
+104
New +$3.64K ﹤0.01% 7187

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada's BCYC Position: Q1 2026 in Review

Royal Bank of Canada increased its Bicycle Therapeutics (BCYC) stake by 35% in Q1 2026, buying an estimated $21.6K and bringing the position to 14,470 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #5343.

Royal Bank of Canada first reported a position in BCYC in Q3 2021 and has held it in 19 quarters since. The position peaked at $152K in Q1 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Royal Bank of Canada held 14,470 shares of Bicycle Therapeutics worth $67K as of Q1 2026.
  • Royal Bank of Canada bought 3,788 Bicycle Therapeutics shares in Q1 2026, an estimated $21.6K.
  • Bicycle Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5343 holding.
  • Royal Bank of Canada first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Bicycle Therapeutics position peaked at $152K in Q1 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.